Skip to content
healthcare.dev

DRX CHOICE Extra Strength Headache Relief

NDC 68163-066, Acetaminophen, Aspirin (NSAID), Caffeine, tablet, film coated, from Raritan Pharmaceuticals Inc..

Product NDC
68163-066
Status
Listed
Labeler
Raritan Pharmaceuticals Inc.
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH DRUG
Application
M013
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68163-066 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ACETAMINOPHEN250 mg/1
  • ASPIRIN250 mg/1
  • CAFFEINE65 mg/1

Pharmacologic classes

Anti-Inflammatory Agents, Non-Steroidal [CS]; Central Nervous System Stimulant [EPC]; Central Nervous System Stimulation [PE]; Cyclooxygenase Inhibitors [MoA]; Decreased Platelet Aggregation [PE]; Decreased Prostaglandin Production [PE]; Methylxanthine [EPC]; Nonsteroidal Anti-inflammatory Drug [EPC]; Platelet Aggregation Inhibitor [EPC]; Xanthines [CS]

Package NDCNDC-11Package
68163-066-246816300662424 TABLET, FILM COATED in 1 CARTON (68163-066-24)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 68163-066 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68163-066 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68163-066. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.